Creso Pharma’s acquisition target Halucenex secures deal with Nucro Technics to test psilocybin liquid formulations
It will also provide CPH with the ability to develop and validate methods for potency, component identification and microbiology for botanical psilocybe mushrooms grown in the future at Halucenex. Nucro-Technics employs more than 170 scientific support personnel at its state-of-the-art 60,000 square foot facility in Toronto.
Creso Pharma Ltd s (ASX:CPH) (FRA:1X8) target acquisition Halucenex Life Sciences Inc has signed an agreement with leading pharmaceutical contract research organisation Nucro-Technics to provide microbiology and chemistry test work for a salient delivery solution using synthetic psilocybin, which will be used in upcoming clinical trial submissions.
OTTAWA It has been nearly two years since a civilian employee at the Defence Department says she first lodged a workplace harassment complaint against one of her superiors and she says the bureaucratic stonewalling ever since has left her feeling defeated.
The woman, whom The Canadian Press agreed not to identify because she fears reprisal while she remains employed by the department, says it all started when she was asked to do work outside her job description, which she refused to do.
“As soon as I said, ‘No,’ there was a change in my entire work environment and how I was handled,” she said Tuesday in an interview.
OTTAWA - It has been nearly two years since a civilian employee at the Defence Department says she first lodged a workplace harassment complaint against one of her superiors and she says the bureaucratic stonewalling ever since has left her feeling defeated.
Ville-MarieINTERNATIONAL ‘FLASHMOB’ TREND RESURFACES:The “FlashMob” trend has resurfaced in major cities worldwide. The idea is that groups of artists come together to perform popup dance and music in public places,
More local sectors react to federal budget fftimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fftimes.com Daily Mail and Mail on Sunday newspapers.